Zeneca to double output of tasteless meat substitute
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AN ENTHUSIASTIC response to test marketing of Quorn, the meat substitute, among healthy-eating Europeans has prompted Zeneca, the drugs and agrochemicals arm of Imperial Chemical Industries, to invest pounds 26.5m to double its production in Teesside.
The group plans to build a second fermenting plant for Quorn at its plant in Belasis, Cleveland, which will increase its capacity to 14,000 tonnes - enough for about 28 million meals for a family of four - by 1995.
The expansion comes less than 18 months after it embarked on a pounds 37m programme to increase production at both Belasis and the neighbouring Stokesley plant, where Quorn is flavoured and cut into chunks.
The investment will also create 50 jobs in Teesside, increasing the numbers employed in Quorn production and manufacturing to 250.
The expansion will allow the group to expand into Europe, where market research has indicated an encouraging level of demand. It is already available in Britain, Ireland, Germany and Belgium - where an enthusiastic response to test marketing prompted the retailer Delhaize to make it available nationally within a month of its launch.
Sales in Germany and the Netherlands are to be expanded later this year, and Zeneca is also considering its launch into France and Italy.
Based on a distant relative of the mushroom, Quorn is a high-protein, low-fat food which, because it has no distinctive taste of its own, can be combined with a wide range of ingredients. It is already being used in ready-made meals by supermarket chains such as Sainsbury as well as being sold on its own.
Zeneca would not disclose Quorn's sales, but analysts believe they are running at less than pounds 40m and the high investment means it is unlikely to be making profits. It is, however, one of the products in Zeneca's portfolio that the group believes could be significant contributors to earnings in the future.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments